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The usefulness of a gamma camera system for external imaging of the degradation sites of low-density lipo- 
protein (LDL) is demonstrated in rats. [13*I]LDL was injected intravenously in normal rats and rats pretreat- 
ed with 17~ethinyl estradiol for LDL receptor induction. Distribution of the radioligand was followed for 
20 min, for perfusion cpntrol [‘3’I]albumin was administered. Rats pretreated with 17a-ethinyl estradiol 
showed a marked increase in the LDL uptake by the liver, which was not competed by the preinjection 
of physiological amounts of unlabelled LDL. It is concluded that the injection of small amounts of [‘3’I]LDL 
is sufficient to image the hepatic LDL receptor and that the endogenous LDL does not compete effectively 
at physiological LDL levels. 
Low-density lipoprotein LDL receptor 
1. INTRODUCTION 
It is well documented in studies done in vivo and 
in vitro that the liver of rat pretreated with 17~ 
ethinyl estradiol expresses membrane receptors 
capable of binding human low-density lipoprotein 
(LDL) which mediates the uptake and degradation 
of these particles by the hepatocytes [l-4]. In the 
estradiol-treated rat the liver is the major catabolic 
compartment for the degradation of intravenously 
injected human LDL. In contrast, in normal rats 
there are only small numbers of hepatic LDL 
receptors. After intravenous injection of human 
LDL into normal rats, the catabolism of LDL is 
directed mainly by receptor-independent mecha- 
nisms. As a result, the removal of LDL from the 
plasma compartment is slow. Thus, 17@-ethinyl 
estradiol-treated rats and normal rats as a control 
might provide favorable circumstances to study the 
kinetics of the LDL receptor mediated uptake of 
LDL in the rat liver. 
feasibility of scintiscans to evaluate receptor activi- 
ty in vivo. We labelled human LDL with 
[13’I]iodine to obtain sufficiently high specific ac- 
tivities by a modification of the method of MC 
Farlane [5] and injected the radioligands into the 
rats. As an indicator for organ perfusion, 
[13’I]albumin was used. Here we compare the up- 
take of [13’I]LDL by the liver in normal rats and 
rats pretreated with 17&-ethinyl estradiol which 
was continuously followed by a gamma camera in- 
terfaced with a computer. The results of this study 
allow us to suggest hat it is possible to evaluate the 
LDL receptor status of the liver by sequential scin- 
tiscans. We conclude that this approach is useful to 
study the kinetics of the LDL metabolism external- 
ly, in other organ compartments and 
well. 
systems as 
2. MATERIALS AND METHODS 
Sodium [1311]iodide with a specific activity of 
The need for external_ but sensitive methods to lo-20 Ci (370-740 GBq)/mg was purchased from 
study the regulation of the metabolism of lipopro- Amersham-Buchler (Braunschweig, FRG). Cremo- 
teins in vivo prompted us to investigate the phor E was obtained from BASF (Ludwigshafen, 
17a-Ethinyl estradiol Scintigraphy 
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FRG). All other chemicals were purchased from and heart regions were averaged for statistical 
Serva (Heidelberg, FRG). variation. 
2.1. Animals, diets and drugs 
Female Sprague-Dawley rats weighing 250 g (10 
weeks old) were used in all experiments. All rats 
were fed a normal rat chow diet. Beginning 5 days 
prior to [t3’I]LDL scintigrams, 1 mg 17a-ethinyl 
estradiol was injected subcutaneously daily. It was 
dissolved first in 10 ~1 ethanol and then in 200 ~1 
cremophor as a dilution mediator and in 800/11 
phosphate-buffered saline (pH 7.2). Control rats 
received equal volumes of diluent. 
3. RESULTS 
The treatment of rats with 17@-ethinyl estradiol 
results in a marked h~olipoproteinemia [9]. In 
our animals we saw a fall in plasma cholesterol 
from 60/rg/dl before treatment to less than 
6 ,ug/dl on day five. 
3.1. Perfusion sc~nt~ca~ of the rat liver 
2.2. Low-density lipoprotein (LDL) 
Human LDL was isolated from plasma of nor- 
mal rats by sequential ultracentrifugation as in [6]. 
The isolated LDL contained apoB as the only 
detectable band on SDS-PAGE. LDL was dialysed 
extensively against 0.15 M NaCI, O.OlVo EDTA 
(pH 7) before use. 
[13iI]LDL was labelled by a modification of the 
procedure of MC Farlane 151, using low concentra- 
tions of chlorine water instead of ICl to generate 
free i3iI+. Excess radioiodine was rapidly removed 
by ultrafiltration using the Centricon system 
(Amicon, Witten, FRG). Protein concentrations 
were determined by the method of Lowry using 
albumin as a standard 171. The specific activities 
for [‘311]LDL were 5~7~ cpmlng (lOOOO- 
15000 dpmlng = 4.5-7 &i/p&). Lipid label was 
determined by butanol/acetone extraction as 
described by Bilheimer et al. [8]. The lipids con- 
tained less than 3% of the radioactivity in all 
experiments. 
Since the application of high doses of 17~- 
ethinyl estradiol might influence the plasma space 
and the perfusion kinetics of the liver, in a series 
of control experiments in three normal rats and 3 
rats pretreated with 17a-ethinyl estradiol, 80 pg 
[1311]albumin (3~-5~ /rCi) was injected in- 
travenously to monitor perfusion of the organ 
compartments. As shown in fig. 1, the distribution 
kinetics of [1311]albumin the liver and heart 
region of normal rats and rats pretreated with 17a- 
ethinyl estradiol obtained before injection of 
[‘3’I]LDL did not differ significantly. Rates of 
removal of r3’I from the circulating compartment 
were not affected (fig.1). 
3.2. Uptake and binding of f”‘Z]LDL by the rat 
liver receptors 
As expected, shortly after intravenous applica- 
tion of the [r3’I]LDL, the radioactivity was detec- 
table in organs with large blood flow, e.g., the 
heart and the liver. Within 20 s after injection, 
radioactivity reached a maximum in the heart 
region, then constantly decreased in the 17a- 
2.3. In vivo studies 
Under anaesthesia with halothane/NzO/Oz 
(1.5 : 40: 60), rats were injected with various 
amounts of [r311]LDL through a tail vein. The 
distribution of the radiolabelled LDL in the body 
was continuously monitored with a pinhole camera 
(Phogamma III, Nuclear Chicago) interfaced with 
a PDP 1 I /30, Digital (Mtinchen, FRG) to monitor 
the data on magtape in list mode. Data recording 
was started 0.5 min before injection. Images were 
taken at selected times. Regions of interest were 
defined. Radioactivity in the heart region was 
taken as being representative for the circulating 
radioactivity. Time-activity curves over the liver 
Fig. 1. Time-activity curves in the liver and neart region 
in a normal rat and a rat treated with 17&-ethinyl 
estradiol O-10 min after intravenous bolus injection of 
80 pg [‘3’IJalbumin = 300&i. Profiles of (A) an 
untreated (= normal) rat, (B) a rat after treatment with 
17cr-ethinyl estradiol (see section 2). 
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ethinyl estradiol-treated rat. Such a decay was not 
seen in the normal rat (fig.2). In contrast, in nor- 
mal rats radioactivity reached an equilibrium in the 
plasma. In the estradiol-treated rat, simultaneous- 
ly to the decay of [1311]LDL in the heart region, 
50% of the plasma LDL was cleared after 20 min 
as compared to less than 11% in the untreated rat. 
Thus the heart region represents agood estimate of 
the circulating radioactivity. 
The time-activity curves in the liver region 
demonstrate that the hepatic uptake of [r311]LDL 
is markedly affected by the estradiol pretreatment. 
B 
Fig.2. Time-activity curves in the heart region of a 
ethinyl estradiol (see section 2). 
normal rat and a rat pretreated with 17cu-ethinyl 
estradiol after intravenous bolus injection through a tail 
vein of 50 pg ‘311-labelled human LDL (400 &i) from 0 
to 20 min. Profiles from the heart region of (A) an 
untreated rat, (B) a rat after pretreatment with 17~ 
. . .: . 
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t 
The removal of [‘311]LDL in estradiol-treated rats 
from the plasma compartment could be attributed 
largely to the uptake of the radioligand by the 
liver. A representative pair of hepatic time-ac- 
tivity profiles from a control and an estradiol- 
treated rat are shown in fig.3. The curves corrected 
for perfusion demonstrate a rapid and constant in- 
crease of [13’I]LDL trapping in the liver region of 
the estradiol-treated rat, binding 25% of the in- 
jected radioactivity 20 min after injection. In con- 
trast, in the experiments with 3 control rats the 
radioactivity in the liver region averaged 3-7070 of 
Fig.3. Time-activity curves in the liver region of a 
normal rat and a rat pretreated with 17cu-ethinyl 
estradiol (see section 2). 
estradiol after injection of a bolus of 5Opg [“‘I]LDL 
(400,&i) through a tail vein from 0 to 20 min. Profiles 
are corrected for perfusion, thus representing 
accumulation of radioactivity due to binding to the 
organ compartment. Profiles from the liver region of 
(A) a normal rat, (B) a rat pretreated with 17cu-ethinyl 
. 
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Fig.4. Sequential scintiscans of a normal rat and a rat pretreated with ethinyl estradiol. (A,B) 5 and 20 min after bolus 
injection of 50 pg 1311-labelled human LDL (400 ,Ki) through a tail vein into a normal rat. (C,D) 5 and 20 min after 
bolus injection of 5Opg “‘I-labelled human LDL with the same specific activity through a tail vein of a rat injected 
daily with 5 mg/kg 17cu-ethinyl estradiol intraperitoneally and an actual plasma cholesterol evel of 3 pg/dl. 
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the injected dose. The differences in the LDL up- 
take in the liver compartments in the normal and 
estradiol-treated rat can be demonstrated nicely in 
total body images. Sequential scintiscans from 
normal and pretreated rats after injection of 
[1311]LDL differentiate the liver and visualize 
clearly the difference in the liver uptake by the nor- 
mal and estradiol-treated rats (fig.4). 
Finally, an attempt was made to investigate 
whether the presence of unlabelled endogenous 
LDL would result in an effective competition with 
the injected [1311]LDL. By preinjection of varying 
amounts of up to 4 mg unlabelled LDL, 10 min 
before the [1311]LDL was applied, it was possible 
to increase the LDL plasma levels even in the 
estradiol-treated rat 2-fold above the plasma levels 
in normal rats. However, our experiments failed to 
demonstrate effective competition. Again, the 
hepatic accumulation of [i3’I]LDL was rapid. 
Liver uptake was not affected at plasma LDL con- 
centrations of 25, 100 and 160 pg/ml unlabelled 
plasma LDL-protein. This is in very good agree- 
ment with earlier reports by others, who quantified 
the hepatic LDL uptake in rats after killing and 
removal of the liver [1,4]. Therefore, we suggest 
that in the presence of physiological LDL plasma 
concentrations in the rat, the influence of competi- 
tion in the presence of physiological endogenous 
LDL levels on the [1311]LDL trapping activity in 
the liver is negligible. 
4. DISCUSSION 
External imaging of receptors for radioligands 
injected intravenously has been used to study the 
kinetics of ligand-receptor interaction in vivo in 
several systems [lo-121. We used this technique to 
‘follow the hepatic LDL receptor activity in the rat 
liver. 
Based on the original observations of Kovanen 
et al. [I], we used normal rats and rats pretreated 
with cY-ethinyl estradiol to demonstrate differences 
in LDL receptor-dependent uptake of LDL in this 
animal system by scintigraphy. It is apparent from 
our studies about the hepatic LDL uptake in vivo 
in normal rats and rats pretreated with 1%~ethinyl 
estradiol that sequential scintiscans and external 
recording of distribution kinetics of the 
radioligand are a very efficient approach to study 
the LDL interaction with the hepatic compartment 
in vivo. In confirmation of the results of Kovanen 
et al. [l], Chao et al. [2] and Koeltz et al. [4] we 
found that after 20 min, approx. 25-30% of the 
clearance of non-saturating amounts of LDL in the 
estradiol-treated rats can be attributed to a specific 
LDL trapping activity induced by 17cu-ethinyl 
estradiol treatment. Some active receptors may 
also be demonstrated in the liver of normal rats 
which cannot be detected by our camera system. 
But under similar conditions, Kovanen et al. have 
shown that the hepatic LDL binding in normal rats 
is less than 10% of the liver of the estradiol-treated 
rat. 
Since the pool size of endogenous LDL in the 
normal rat was greater than in the estradiol-treated 
rat, a possible influence of competition by en- 
dogenous lipoproteins in the normal rat could have 
affected the results. But neither the fractional 
catabolic rate nor the hepatic uptake kinetic was 
altered effectively in the presence of concentra- 
tions of unlabelled LDL as high as 160pg/ml, 
which is 2-times the physiological evels of the nor- 
mal rat. The failure to demonstrate competition at 
this concentration by endogenous LDL can be ex- 
plained following the results of Kovanen et al. [l]. 
These investigators could calculate that half max- 
imal concentration for LDL uptake in vivo in the 
estradiol-treated rat is 744 gg LDL-protein/ml, 
well above the concentration of the endogenous 
LDL. If this can be assumed - and our own experi- 
ment in the presence of high levels of endogenous 
LDL provides additional evidence - the data ob- 
tained by sequential scintiscans in the presence of 
physiological concentrations of endogenous LDL 
would reflect closely the in vivo LDL receptor ac- 
tivity. Thus, the use of LDL with high specific ac- 
tivities and a conventional gamma camera system 
to generate sequential images of LDL receptor 
compartments is a favorable approach to studying 
in vivo conditions. 
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